TrialJAMA network open2025

Dual Immune Checkpoint Inhibition Plus Neoadjuvant Chemoradiotherapy in Rectal Cancer: A Randomized Clinical Trial.

Johannes Laengle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.